Book Excerpt from The Power of Rare

In chapter 4, “Building a Cure Machine,” author Victoria Jackson reveals the challenges in launching a foundation focused on funding research on a rare disease.

Written byMichael Yeaman and Victoria Jackson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Regan Arts, September 2017Curing a disease is not for wimps.

Even before the ink was dry on our foundation charter, that was something I knew instinctively. And it has served as a mantra ever since—a reminder that has kept me on my feet, especially on those fearful days when all I’ve wanted to do was curl up in a fetal position in the corner. Now that we’d gotten everyone into the room and had created incentives for sharing, the greater challenge was figuring out how to translate all that brilliance and life-saving science and patient insight into the moving parts of a real-world, practical delivery mechanism for change.

Such was the vision for our cure machine.

Questions and challenges abounded. Not just what had to be done—but how. How did we connect and synchronize our ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies